Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, Beig S, Berkovitch M.
Drug Saf. 2010 Sep 1;33(9):713-26. doi: 10.2165/11536520-000000000-00000.
Drug-induced haemolytic anemia.
Petz LD, Garratty G.
Clin Haematol. 1975 Feb;4(1):181-97.
Drug-induced anaemias.
Girdwood RH.
Drugs. 1976;11(5):394-404. doi: 10.2165/00003495-197611050-00003.
Wilson Disease Agents.
[No authors listed]
2020 Jul 25. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
The Phenomenon of Thrombotic Microangiopathy in Cancer Patients.
Vorobev A, Bitsadze V, Yagubova F, Khizroeva J, Solopova A, Tretyakova M, Gashimova N, Grigoreva K, Einullaeva S, Drozhzhina M, Hajiyeva A, Khalilulina E, Cherepanov A, Kapanadze D, Egorova E, Kuneshko N, Gris JC, Elalamy I, Ay C, Makatsariya A.
Int J Mol Sci. 2024 Aug 21;25(16):9055. doi: 10.3390/ijms25169055.
[PHARMACOGENETICS].
JOERGENSEN G.
Med Welt. 1964 Jan 4;1:16-23.
Feline hepatic disease.
Zawie DA, Garvey MS.
Vet Clin North Am Small Anim Pract. 1984 Nov;14(6):1201-30. doi: 10.1016/s0195-5616(84)50154-5.
[ON PHARMACOGENETICS].
RUMLER W.
Dtsch Gesundheitsw. 1963 Aug 22;18:1477-82.
Phenacetin-induced hemolytic anemia.
Millar J, Péloquin R, De Leeuw NK.
Can Med Assoc J. 1972 Apr 8;106(7):770-5.
An hereditary enzymatic defect in red blood cells; its relation to certain drug-induced hemolytic anemias.
GROSS RT, MARKS PA.
Ann N Y Acad Sci. 1958 Oct 13;75(1):106-9. doi: 10.1111/j.1749-6632.1958.tb36854.x.
